ValenTx Receives $22,000,000 Series B Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    200 Homedale Rd Carpinteria, CA 93013
  • Company Description
    The company is developing less invasive treatments for morbid obesity.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series B
  • Proceeds Purposes
    With this financing we will continue our Company’s development with the goal of offering a safe and effective treatment option for morbid obesity to help address the challenge this problem presents to our global community.
  • M&A Terms
  • Venture Investor
    SV Life Sciences
  • Venture Investor
    Covidien Ventures
  • Venture Investor
    Sapient Capital
  • Venture Investor
    EDF Ventures
  • Venture Investor
    Kaiser Permanente Ventures
  • Venture Investor
    Affinity Capital
  • Venture Investor
    TGap Ventures

Trending on Xconomy